These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. Martina MS; Fortin JP; Ménager C; Clément O; Barratt G; Grabielle-Madelmont C; Gazeau F; Cabuil V; Lesieur S J Am Chem Soc; 2005 Aug; 127(30):10676-85. PubMed ID: 16045355 [TBL] [Abstract][Full Text] [Related]
26. [Liposomes--therapeutic progress and technological problems]. Szulc J; Dudzik M; Woyczikowski B; Sznitowska M; Janicki S Pol Merkur Lekarski; 2002 Feb; 12(68):164-8. PubMed ID: 11995258 [TBL] [Abstract][Full Text] [Related]
27. Binding characteristics and thermal behaviour of cytochrome-C oxidase, inserted into phospholipid-coated, magnetic nanoparticles. de Cuyper M; Joniau M Biotechnol Appl Biochem; 1992 Oct; 16(2):201-10. PubMed ID: 1333772 [TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of indomethacin magnetic nanoparticles. Malaiya A; Vyas SP J Microencapsul; 1988; 5(3):243-53. PubMed ID: 3199309 [TBL] [Abstract][Full Text] [Related]
30. Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Chunfu Z; Jinquan C; Duanzhi Y; Yongxian W; Yanlin F; Jiajü T Appl Radiat Isot; 2004 Dec; 61(6):1255-9. PubMed ID: 15388118 [TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. Zhu L; Huo Z; Wang L; Tong X; Xiao Y; Ni K Int J Pharm; 2009 Mar; 370(1-2):136-43. PubMed ID: 19114095 [TBL] [Abstract][Full Text] [Related]
34. Microdialysis assessment of 5-fluorouracil release from thermosensitive magnetoliposomes induced by an electromagnetic field in tumor-bearing mice. Viroonchatapan E; Sato H; Ueno M; Adachi I; Murata J; Saiki I; Tazawa K; Horikoshi I J Drug Target; 1998; 5(5):379-90. PubMed ID: 9771619 [TBL] [Abstract][Full Text] [Related]
35. Magnetoliposomes in Controlled-Release Drug Delivery Systems. Tomitaka A; Takemura Y; Huang Z; Roy U; Nair M Crit Rev Biomed Eng; 2019; 47(6):495-505. PubMed ID: 32421974 [TBL] [Abstract][Full Text] [Related]
36. Multifunctional Magnetoliposomes for Sequential Controlled Release. Salvatore A; Montis C; Berti D; Baglioni P ACS Nano; 2016 Aug; 10(8):7749-60. PubMed ID: 27504891 [TBL] [Abstract][Full Text] [Related]
37. Microfluidic one-step synthesis of Fe₃O₄-chitosan composite particles and their applications. Yang CH; Wang CY; Huang KS; Kung CP; Chang YC; Shaw JF Int J Pharm; 2014 Mar; 463(2):155-60. PubMed ID: 23988565 [TBL] [Abstract][Full Text] [Related]
38. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells. Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822 [TBL] [Abstract][Full Text] [Related]
39. Cationic magnetoliposomes. De Cuyper M; Soenen SJ Methods Mol Biol; 2010; 605():97-111. PubMed ID: 20072875 [TBL] [Abstract][Full Text] [Related]
40. Low-cost, easy-to-prepare magnetic chitosan microparticles for enzymes immobilization. Pospiskova K; Safarik I Carbohydr Polym; 2013 Jul; 96(2):545-8. PubMed ID: 23768599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]